share_log

UnitedHealth | 8-K: UnitedHealth Group Reports Second Quarter 2024 Results

UnitedHealth | 8-K: UnitedHealth Group Reports Second Quarter 2024 Results

聯合健康 | 8-K:UnitedHealth 集團公佈2024年第二季度業績
美股SEC公告 ·  07/16 18:07
牛牛AI助理已提取核心訊息
UnitedHealth Group Incorporated reported its second quarter 2024 financial results on July 16, 2024. The company saw revenues of $98.9 billion, a nearly $6 billion increase year over year, primarily driven by growth in Optum and UnitedHealthcare's domestic offerings. UnitedHealthcare's commercial offerings grew by 2.3 million consumers year to date. The company's cash flows from operations were strong at $6.7 billion, 1.5 times the net income. However, the quarter's earnings were impacted by the classification of South American operations as held for sale and the effects of a cyberattack. Adjusted earnings per share were $6.80, including business disruption impacts of $0.28 per share. The cyberattack impacts totaled $0.92 per share for the quarter, with the company providing over $9 billion in support to affected care providers. UnitedHealth updated...Show More
UnitedHealth Group Incorporated reported its second quarter 2024 financial results on July 16, 2024. The company saw revenues of $98.9 billion, a nearly $6 billion increase year over year, primarily driven by growth in Optum and UnitedHealthcare's domestic offerings. UnitedHealthcare's commercial offerings grew by 2.3 million consumers year to date. The company's cash flows from operations were strong at $6.7 billion, 1.5 times the net income. However, the quarter's earnings were impacted by the classification of South American operations as held for sale and the effects of a cyberattack. Adjusted earnings per share were $6.80, including business disruption impacts of $0.28 per share. The cyberattack impacts totaled $0.92 per share for the quarter, with the company providing over $9 billion in support to affected care providers. UnitedHealth updated its full-year 2024 net earnings outlook to $15.95 to $16.40 per share, reflecting these impacts, but maintained its adjusted net earnings outlook of $27.50 to $28.00 per share. The company completed the sale of its larger Brazilian operations in the first quarter of 2024 and intends to sell its remaining South American operations. The second quarter's operating cost ratio improved to 13.3% from 14.9% in 2023, indicating continued cost efficiency.
聯合健康集團公佈了2024年第二季度的財務報告,於2024年7月16日發佈。該公司的營收爲989億美元,同比增長近60億美元,主要源於Optum和聯合健康醫療保健業務在國內的增長。聯合健康保健業務的商業增長至今已增加了230萬客戶。該公司運營現金流強勁,達到了67億美元,是淨利潤的1.5倍。然而,本季度的收益受到南美業務的出售分類和網絡攻擊影響。每股調整後收益爲6.80美元,其中包括每股0.28美元的業務中斷影響。本季度的網絡攻擊影響總計爲每股0.92美元,公司提供了超過90億美元的支持給受影響的醫療保健服務提供商。聯合健康更新了2024年全年的淨收益預期,爲每股15.95美元至16.40美元...展開全部
聯合健康集團公佈了2024年第二季度的財務報告,於2024年7月16日發佈。該公司的營收爲989億美元,同比增長近60億美元,主要源於Optum和聯合健康醫療保健業務在國內的增長。聯合健康保健業務的商業增長至今已增加了230萬客戶。該公司運營現金流強勁,達到了67億美元,是淨利潤的1.5倍。然而,本季度的收益受到南美業務的出售分類和網絡攻擊影響。每股調整後收益爲6.80美元,其中包括每股0.28美元的業務中斷影響。本季度的網絡攻擊影響總計爲每股0.92美元,公司提供了超過90億美元的支持給受影響的醫療保健服務提供商。聯合健康更新了2024年全年的淨收益預期,爲每股15.95美元至16.40美元,反映了這些影響,但保持了每股調整後淨收益的預期在27.50美元至28.00美元之間。該公司已在2024年第一季度完成了其更大的巴西業務出售,並計劃出售其餘的南美業務。第二季度的運營成本收入比率從2023年的14.9%改善至13.3%,表明成本效益持續提高。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。